Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPP | RAPPORT THERAPEUTICS INC | $1.94B | $40.45 | $62.25 | 53.89% | Strong Buy | 4 | N/A | N/A | -57.16% | -52.67% | |||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.03B | $12.13 | $27.25 | 124.65% | Strong Buy | 4 | -43.05% | N/A | -36.97% | -26.06% | |||
| BLSM | BLOSSOMHILL THERAPEUTICS INC | $818.14M | $25.74 | $31.00 | 20.44% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| AVTX | AVALO THERAPEUTICS INC | $888.65M | $16.57 | $45.73 | 175.96% | Strong Buy | 11 | -100.00% | N/A | -29.77% | -27.22% | |||
| AHCO | ADAPTHEALTH CORP | $778.53M | $5.71 | $10.83 | 89.72% | Strong Buy | 6 | 1.49% | N/A | 14.43% | 4.58% | |||
| STTK | SHATTUCK LABS INC | $603.18M | $6.01 | $14.86 | 147.20% | Strong Buy | 8 | -100.00% | N/A | -28.03% | -26.82% | |||
| IFRX | INFLARX NV | $308.00M | $2.09 | $9.00 | 330.62% | Strong Buy | 5 | N/A | N/A | -39.87% | -34.92% | |||
| PPLI | PEOPLE INC | $2.69B | $36.19 | $55.25 | 52.67% | Strong Buy | 12 | -3.09% | -59.37% | 3.15% | 2.14% | |||
| SABS | SAB BIOTHERAPEUTICS INC | $319.36M | $3.51 | $12.29 | 250.03% | Strong Buy | 7 | N/A | N/A | -35.86% | -32.34% | |||
| GUTS | FRACTYL HEALTH INC | $95.51M | $0.60 | $6.67 | 1,011.17% | Strong Buy | 3 | N/A | N/A | -715.11% | 14.52% | |||
| RLMD | RELMADA THERAPEUTICS INC | $439.48M | $4.12 | $14.33 | 247.89% | Strong Buy | 3 | N/A | N/A | -43.19% | -40.73% | |||
| AADX | APPLIED AEROSPACE & DEFENSE INC | $2.20B | $12.76 | $25.83 | 102.45% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| IMUX | IMMUNIC INC | $144.90M | $10.62 | $37.80 | 255.93% | Strong Buy | 6 | N/A | N/A | -6.89% | -5.53% | |||
| SCTX | SCRIBE THERAPEUTICS INC | $624.75M | $33.00 | $51.75 | 56.82% | Strong Buy | 4 | N/A | N/A | N/A | -142.23% | |||
| MSTR | STRATEGY INC | $59.14B | $153.92 | $232.82 | 51.26% | Strong Buy | 11 | 2.28% | N/A | 16.80% | 9.87% | |||
| TFII | TFI INTERNATIONAL INC | $10.29B | $125.16 | $175.00 | 39.82% | Strong Buy | 11 | N/A | N/A | N/A | N/A | |||
| ASMB | ASSEMBLY BIOSCIENCES INC | $508.40M | $24.97 | $47.50 | 90.23% | Strong Buy | 4 | N/A | N/A | -22.46% | -20.75% | |||
| ELTX | ELICIO THERAPEUTICS INC | $49.67M | $1.89 | $20.50 | 984.66% | Strong Buy | 5 | N/A | N/A | -1,351.02% | -342.26% | |||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $1.38B | $38.60 | $64.90 | 68.13% | Strong Buy | 10 | N/A | N/A | -84.75% | -78.11% | |||
| PAC | PACIFIC AIRPORT GROUP | $10.25B | $202.78 | $261.67 | 29.04% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.64B | $77.30 | $94.67 | 22.47% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| XNCR | XENCOR INC | $1.84B | $24.72 | $31.86 | 28.87% | Strong Buy | 7 | 5.19% | N/A | -36.76% | -25.51% | |||
| AKBA | AKEBIA THERAPEUTICS INC | $253.83M | $0.92 | $3.88 | 323.03% | Strong Buy | 4 | -8.47% | N/A | -84.73% | -6.06% | |||
| ECHO | ECHOSTAR CORP | $27.15B | $93.46 | $133.50 | 42.84% | Strong Buy | 6 | -4.28% | N/A | -1.17% | -0.42% | |||
| GIII | G III APPAREL GROUP LTD | $1.18B | $27.57 | $37.33 | 35.41% | Strong Buy | 3 | 0.00% | -5.85% | 6.85% | 4.53% | |||
| PCOR | PROCORE TECHNOLOGIES INC | $7.79B | $51.27 | $67.80 | 32.24% | Strong Buy | 10 | 11.98% | N/A | N/A | N/A | |||
| LONA | LEONABIO INC | $63.97M | $6.79 | $17.33 | 155.27% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| WVE | WAVE LIFE SCIENCES INC | $857.16M | $4.35 | $20.22 | 364.87% | Strong Buy | 9 | 6.12% | N/A | -28.31% | -22.99% | |||
| IMMX | IMMIX BIOPHARMA INC | $894.24M | $12.50 | $23.50 | 88.00% | Strong Buy | 6 | N/A | N/A | 16.42% | 15.72% | |||
| SKHY | SK HYNIX INC | N/A | $187.50 | $248.00 | 32.27% | Strong Buy | 9 | N/A | N/A | N/A | N/A | |||
| NKTR | NEKTAR THERAPEUTICS | $2.29B | $67.10 | $143.43 | 113.75% | Strong Buy | 7 | -13.41% | N/A | -46.00% | -37.94% | |||
| SPRB | SPRUCE BIOSCIENCES INC | $152.47M | $53.05 | $140.29 | 164.44% | Strong Buy | 7 | N/A | N/A | -2.29% | -1.87% | |||
| CABA | CABALETTA BIO INC | $432.34M | $2.55 | $15.60 | 511.76% | Strong Buy | 5 | N/A | N/A | -87.05% | -71.40% | |||
| JMKE | JERSEY MIKE's SUBS INC | $6.22B | $19.58 | $27.95 | 42.76% | Strong Buy | 23 | N/A | N/A | 4.80% | 3.44% | |||
| AGMB | AGOMAB THERAPEUTICS NV | $593.13M | $12.17 | $43.00 | 253.33% | Strong Buy | 4 | N/A | N/A | -25.84% | -23.57% | |||
| IRON | DISC MEDICINE INC | $2.67B | $69.53 | $97.75 | 40.59% | Strong Buy | 4 | N/A | N/A | -16.19% | -14.19% | |||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.39B | $66.48 | $102.09 | 53.57% | Strong Buy | 11 | -3.96% | N/A | -65.12% | -14.35% | |||
| LTRX | LANTRONIX INC | $273.23M | $5.85 | $11.00 | 88.03% | Strong Buy | 4 | 12.62% | N/A | N/A | N/A | |||
| TLX | TELIX PHARMACEUTICALS LTD | $4.28B | $12.59 | $21.33 | 69.44% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.68B | $46.65 | $69.50 | 48.98% | Strong Buy | 10 | N/A | N/A | -8.81% | -4.27% | |||
| BRSP | BRIGHTSPIRE CAPITAL INC | $525.08M | $4.15 | $6.67 | 60.65% | Strong Buy | 3 | -37.32% | N/A | 9.42% | 2.17% | |||
| ARVN | ARVINAS INC | $542.05M | $8.29 | $16.29 | 96.45% | Strong Buy | 7 | -35.50% | N/A | -24.71% | -20.58% | |||
| INFQ | INFLEQTION INC | $2.98B | $13.23 | $21.40 | 61.75% | Strong Buy | 5 | 9.89% | N/A | N/A | N/A | |||
| ACRS | ACLARIS THERAPEUTICS INC | $809.59M | $5.50 | $10.60 | 92.73% | Strong Buy | 5 | -10.84% | N/A | -106.29% | -73.69% | |||
| ADTN | ADTRAN HOLDINGS INC | $586.67M | $7.20 | $15.25 | 111.81% | Strong Buy | 4 | 6.24% | N/A | N/A | N/A | |||
| TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $2.25T | $434.67 | $541.29 | 24.53% | Strong Buy | 7 | N/A | N/A | N/A | N/A | |||
| CNTX | CONTEXT THERAPEUTICS INC | $33.81M | $0.37 | $6.25 | 1,598.37% | Strong Buy | 4 | N/A | N/A | -116.86% | -96.69% | |||
| ATHE | ALTERITY THERAPEUTICS LTD | $70.59M | $3.91 | $12.00 | 206.91% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| BTGO | BITGO HOLDINGS INC | $888.64M | $7.56 | $11.50 | 52.12% | Strong Buy | 9 | -74.34% | N/A | 18.54% | 1.30% | |||
| VKTX | VIKING THERAPEUTICS INC | $3.38B | $28.99 | $99.17 | 242.07% | Strong Buy | 6 | N/A | N/A | -43.00% | -33.64% | |||
| SEPN | SEPTERNA INC | $1.81B | $38.69 | $52.43 | 35.51% | Strong Buy | 7 | -11.53% | N/A | -38.90% | -26.55% | |||
| SGRY | SURGERY PARTNERS INC | $1.73B | $13.25 | $17.75 | 33.96% | Strong Buy | 4 | 3.00% | N/A | 9.43% | 1.96% | |||
| COAG | HEMAB THERAPEUTICS HOLDINGS INC | $1.92B | $41.19 | $51.40 | 24.79% | Strong Buy | 5 | N/A | N/A | -39.96% | -38.81% | |||
| GENB | GENERATE BIOMEDICINES INC | $2.20B | $17.14 | $26.40 | 54.03% | Strong Buy | 6 | N/A | N/A | -56.55% | -45.92% | |||
| ZGN | ERMENEGILDO ZEGNA NV | $3.30B | $12.29 | $14.83 | 20.69% | Strong Buy | 3 | 1.34% | N/A | 11.76% | 3.95% | |||
| BWAY | BRAINSWAY LTD | $533.05M | $13.61 | $19.27 | 41.57% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| ABVX | ABIVAX SA | $8.29B | $105.04 | $154.30 | 46.90% | Strong Buy | 10 | N/A | N/A | N/A | N/A | |||
| ELAN | ELANCO ANIMAL HEALTH INC | $11.20B | $22.42 | $30.33 | 35.29% | Strong Buy | 6 | 4.83% | N/A | 11.27% | 5.47% | |||
| TYRA | TYRA BIOSCIENCES INC | $1.54B | $25.73 | $48.71 | 89.33% | Strong Buy | 8 | N/A | N/A | -49.05% | -45.25% | |||
| NKTX | NKARTA INC | $202.70M | $2.83 | $11.75 | 315.19% | Strong Buy | 4 | N/A | N/A | -42.32% | -31.05% | |||
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $222.90M | $3.11 | $9.00 | 189.39% | Strong Buy | 3 | N/A | N/A | -18.58% | -12.39% | |||
| AKTS | AKTIS ONCOLOGY INC | $1.22B | $21.88 | $36.67 | 67.58% | Strong Buy | 7 | N/A | N/A | -37.68% | -32.76% | |||
| VCYT | VERACYTE INC | $3.20B | $39.80 | $56.50 | 41.98% | Strong Buy | 10 | 9.84% | 0.25% | 11.84% | 11.06% | |||
| LTM | LATAM AIRLINES GROUP SA | $29.37B | $51.15 | $66.75 | 30.50% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $253.90M | $8.71 | $13.00 | 49.25% | Strong Buy | 8 | N/A | N/A | N/A | N/A | |||
| CEVA | CEVA INC | $852.22M | $30.27 | $43.88 | 44.95% | Strong Buy | 8 | 11.79% | N/A | 9.17% | 7.96% | |||
| SLDB | SOLID BIOSCIENCES INC | $955.38M | $8.91 | $19.50 | 118.86% | Strong Buy | 10 | N/A | N/A | -3.12% | -2.77% | |||
| QNT | QUANTINUUM INC | $13.58B | $51.58 | $98.83 | 91.61% | Strong Buy | 13 | N/A | N/A | -78.45% | -10.03% | |||
| OMAB | CENTRAL NORTH AIRPORT GROUP | $4.70B | $97.45 | $134.00 | 37.51% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| CRVO | CERVOMED INC | $36.74M | $2.43 | $24.67 | 915.10% | Strong Buy | 3 | -100.00% | N/A | -72.54% | -64.08% | |||
| CX | CEMEX SAB DE CV | $14.59B | $10.06 | $14.60 | 45.13% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| CGEM | CULLINAN THERAPEUTICS INC | $1.36B | $21.08 | $37.33 | 77.10% | Strong Buy | 3 | N/A | N/A | -57.33% | -50.70% | |||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $840.82M | $15.22 | $28.50 | 87.25% | Strong Buy | 4 | -18.31% | N/A | -41.57% | -34.40% | |||
| XNDU | XANADU QUANTUM TECHNOLOGIES LTD | $2.26B | $7.42 | $33.00 | 344.74% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| JHX | JAMES HARDIE INDUSTRIES PLC | $14.99B | $25.82 | $35.17 | 36.20% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| PAAS | PAN AMERICAN SILVER CORP | $21.07B | $49.99 | $62.50 | 25.03% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| MSLE | SATELLOS BIOSCIENCE INC | $194.21M | $9.32 | $20.33 | 118.17% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $766.74M | $12.37 | $47.50 | 283.99% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| KLRA | KAILERA THERAPEUTICS INC | $1.66B | $12.83 | $38.00 | 196.18% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| BLND | BLEND LABS INC | $281.45M | $1.19 | $2.98 | 150.00% | Strong Buy | 4 | 5.36% | N/A | -39.46% | 20.44% | |||
| SGMT | SAGIMET BIOSCIENCES INC | $689.34M | $11.09 | $27.95 | 152.05% | Strong Buy | 6 | N/A | N/A | -25.28% | -24.58% | |||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $144.67M | $7.48 | $37.50 | 401.34% | Strong Buy | 6 | N/A | N/A | -87.88% | -70.75% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $22.15M | $2.22 | $20.33 | 815.90% | Strong Buy | 3 | N/A | N/A | -5.69% | -4.73% | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $859.23M | $9.82 | $41.20 | 319.55% | Strong Buy | 6 | N/A | N/A | -44.98% | -39.80% | |||
| FTH | FAETH THERAPEUTICS INC | $891.49M | $34.50 | $57.00 | 65.22% | Strong Buy | 13 | N/A | N/A | -181.35% | -165.68% | |||
| MBX | MBX BIOSCIENCES INC | $3.03B | $62.91 | $84.60 | 34.48% | Strong Buy | 5 | N/A | N/A | -46.84% | -44.01% | |||
| NVCT | NUVECTIS PHARMA INC | $716.79M | $22.00 | $36.00 | 63.64% | Strong Buy | 3 | N/A | N/A | -541.57% | -219.81% | |||
| OSTX | OS THERAPIES INC | $81.64M | $1.77 | $13.33 | 653.28% | Strong Buy | 3 | N/A | N/A | N/A | -23.77% | |||
| KARD | KARDIGAN INC | $1.56B | $16.64 | $42.25 | 153.91% | Strong Buy | 4 | N/A | N/A | -58.45% | -49.85% | |||
| WHWK | WHITEHAWK THERAPEUTICS INC | $239.44M | $4.20 | $9.00 | 114.29% | Strong Buy | 3 | N/A | N/A | -35.29% | -33.27% | |||
| BNTX | BIONTECH SE | $24.29B | $96.06 | $124.00 | 29.09% | Strong Buy | 9 | -8.57% | N/A | -5.01% | -4.37% | |||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $935.29M | $3.41 | $6.87 | 101.50% | Strong Buy | 7 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.